Showing results (41-50 of 515) with videos related to
Sort By:
Pageof 52
Frontiers in Oncology|October 28, 2021
SARS-CoV-2 Infection in Cancer Patients: A Population-Based StudyManuel Zorzi, Stefano Guzzinati, Francesco Avossa, et al.Scandinavian Journal of Gastroenterology|April 22, 2005
Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori: scratch and winMonica Franco, Massimo Rugge, Emma D'Andrea, et al.Pathology Oncology Research : POR|June 14, 2011
Hepatoid adenocarcinoma of the colon: what should we target?Alessandro Cappetta, Francesca Bergamo, Claudia Mescoli, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|July 20, 2011
Anterior gradient 2 overexpression in lung adenocarcinomaMarco Pizzi, Matteo Fassan, Mariangela Balistreri, et al.Best Practice & Research. Clinical Gastroenterology|July 2, 2013
Precancerous lesions in the stomach: from biology to clinical patient managementMassimo Rugge, Lisette G Capelle, Rocco Cappellesso, et al.Gastrointestinal Endoscopy|June 23, 2020
Prevalence of Barrett's esophagus and performance of societal screening guidelines in an unreferred primary care population of U.S. veteransTheresa H Nguyen, Aaron P Thrift, Massimo Rugge, et al.Scandinavian Journal of Gastroenterology|April 23, 2010
Hepatic spleen nodules (HSN)Claudia Mescoli, Carlo Castoro, Adriana Sergio, et al.European Journal of Gastroenterology & Hepatology|October 11, 2005
Non-invasive neoplasia of the stomachMassimo Rugge, Donato Nitti, Fabio Farinati, et al.Digestive Diseases (Basel, Switzerland)|February 5, 2023
Incomplete Intestinal Metaplasia Is Rare in Autoimmune GastritisRobert M Genta, Kevin O Turner, Cristian Robiou, et al.Helicobacter|May 20, 2003
Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer?Fabio Farinati, Romilda Cardin, Valentina M Russo, et al.Pageof 52